In glioblastoma, MHC-I downregulation in GBM has been mechanistically linked to TP53 loss-of-function mutations, which transcriptionally repress key components of the antigen-processing machinery, including TAP1 and ERAP1. The gene discussed is TP53; the disease is glioblastoma.